Study Casts Doubt on Use of Beta Blockers Post-Heart Attack, Especially for Women
WEDNESDAY, Sept. 3, 2025 (HealthDay News) — A drug commonly prescribed to heart attack survivors may not benefit many of them, a new clinical trial has found. Beta-blockers do not appear to reduce the risk of death, a second heart attack or heart failure in people’s whose hearts weren’t damagedContinue Reading










